StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) stock

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3086% above fair value
$272.70−6.00 (-2.15%)

Close on Nov 18, 2026Market cap $656.47BP/E 41.4Yield 1.88%

Johnson & Johnson operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Johnson & Johnson's operating cash flow for the twelve months ending Sep 27, 2026 was $26.16B, up 8.1% year over year. For fiscal 2025 it was $24.53B, up 1.1% from the year before. Over ten years it grew 2.3% a year on average. The highest annual figure on record is $24.53B in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 28, 2025$24.53B+1.1%
FY2024Dec 29, 2024$24.27B+6.5%
FY2023Dec 31, 2023$22.79B+7.5%
FY2022Jan 1, 2023$21.19B-9.5%
FY2021Jan 2, 2022$23.41B-0.5%
FY2020Jan 3, 2021$23.54B+0.5%
FY2019Dec 29, 2019$23.42B+5.5%
FY2018Dec 30, 2018$22.20B+5.4%
FY2017Dec 31, 2017$21.06B+12.2%
FY2016Jan 1, 2017$18.77B-4.1%
FY2015Jan 3, 2016$19.57B+4.6%
FY2014Dec 28, 2014$18.71B+7.4%
FY2013Dec 29, 2013$17.41B+13.1%
FY2012Dec 30, 2012$15.40B+7.7%
FY2011Jan 1, 2012$14.30B-12.7%
FY2010Jan 2, 2011$16.39B-1.1%
FY2009Jan 3, 2010$16.57B+10.7%
FY2008Dec 28, 2008$14.97B-0.3%
FY2007Dec 30, 2007$15.02B–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 2026$7.72B-15.8%
Q2 FY2026Jun 28, 2026$8.62B+122.2%
Q1 FY2026Mar 29, 2026$2.51B-39.8%
Q4 FY2025Dec 28, 2025$7.31B+4.7%
Q3 FY2025Sep 28, 2025$9.17B+14.7%
Q2 FY2025Jun 29, 2025$3.88B-31.2%
Q1 FY2025Mar 30, 2025$4.17B+14.1%
Q4 FY2024Dec 29, 2024$6.98B-11.2%
Q3 FY2024Sep 29, 2024$7.99B+6.7%
Q2 FY2024Jun 30, 2024$5.63B+34.7%
Q1 FY2024Mar 31, 2024$3.66B+12.3%
Q4 FY2023Dec 31, 2023$7.86B+47.0%
Q3 FY2023Oct 1, 2023$7.49B+19.2%
Q2 FY2023Jul 2, 2023$4.18B-25.1%
Q1 FY2023Apr 2, 2023$3.26B-18.1%
Q4 FY2022Jan 1, 2023$5.35B-6.7%
Q3 FY2022Oct 2, 2022$6.28B-24.2%
Q2 FY2022Jul 3, 2022$5.58B+5.0%
Q1 FY2022Apr 3, 2022$3.98B-2.3%
Q4 FY2021Jan 2, 2022$5.73B-31.3%
Q3 FY2021Oct 3, 2021$8.29B-1.1%
Q2 FY2021Jul 4, 2021$5.31B+53.9%
Q1 FY2021Apr 4, 2021$4.07B+21.3%
Q4 FY2020Jan 3, 2021$8.34B+30.4%
Q3 FY2020Sep 27, 2020$8.38B+11.4%
Q2 FY2020Jun 28, 2020$3.45B-42.0%
Q1 FY2020Mar 29, 2020$3.36B-5.2%
Q4 FY2019Dec 29, 2019$6.40B+2.5%
Q3 FY2019Sep 29, 2019$7.53B+20.0%
Q2 FY2019Jun 30, 2019$5.95B-2.2%
Q1 FY2019Mar 31, 2019$3.54B-1.7%
Q4 FY2018Dec 30, 2018$6.24B+2.3%
Q3 FY2018Sep 30, 2018$6.27B+0.1%
Q2 FY2018Jul 1, 2018$6.08B+5.3%
Q1 FY2018Apr 1, 2018$3.61B+23.8%
Q4 FY2017Dec 31, 2017$6.11B-8.2%
Q3 FY2017Oct 1, 2017$6.27B–
Q2 FY2017Jul 2, 2017$5.77B–
Q1 FY2017Apr 2, 2017$2.91B–
Q4 FY2016Jan 1, 2017$6.65B–

More Johnson & Johnson figures

See a number that looks wrong?